Resultados de la búsqueda 31-40 de 26011 para ���������������������������������������������������KaKaoTalk:PC53���24������ ������������ ������������������ ������������ ������������ ���������

  1. Lucinactant (Intratracheal Route) Side Effects - Mayo Clinic

    Lucinactant injection is used to prevent respiratory distress syndrome (RDS) in premature infants at risk for RDS. RDS is a breathing or lung problem which is ...

  2. Bedaquiline (Oral Route) Before Using - Mayo Clinic

    If you missed a dose during weeks 3 to 24, take the missed dose as soon as possible and then go back to your normal dosing schedule. Storage. Keep out of the ...

  3. Meningococcal Vaccine, Diphtheria Conjugate (Intramuscular Route) Before Using - Mayo Clinic

    Meningococcal diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria. The vaccine ...

  4. Plerixafor (Subcutaneous Route) Before Using - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  5. Esterified Estrogens And Methyltestosterone (Oral Route) Before Using - Mayo Clinic

    Talk with your doctor about this risk. If you have vaginal bleeding with this medicine, call your doctor right away. This medicine may increase the risk of ...

  6. Nicotine Dependence Center Residential Treatment Program ServicesCharges MC206611

    Page 1. Page 2.

  7. Patient Statements Sample-1B jp

    Page 1. Page 2.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...

  9. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

  10. Enfermedades alérgicas - Ensayos clínicos - Mayo Clinic

    This is a multicentre, randomised, double-blind (DB), parallel-group, placebo-controlled, 24-week Phase 3 study to compare the efficacy and safety of ...